2 unknown, 1 not yet recruiting, 1 recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 2, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Furosemide 40 mg: new trials by email Literature Review of Furosemide 40 mg trials Research Report on Furosemide 40 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer Duloxetine 60 MG, Furosemide 40 mg, Booklet for healthy behaviors - ER+ Breast Cancer, HER2-negative Breast Cancer | Phase 3 | Not yet recruiting | European Organisation for Research and Treatment of Cancer - EORTC | 399 | 2024-12-01 | 2024-11-05 |
| The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases Furosemide 40 mg, Levodropropizine, Placebo - saline - Dyspnea | Phase 2 / Phase 3 | Unknown | University Hospital Hradec Kralove | 102 | 2024-02-27 | 2024-04-16 |
| Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser Furosemide 40 mg - Kidney Stone | Phase 3 | Recruiting | University Hospital, Tours | 374 | 2024-01-04 | 2026-11-09 |
| Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi Furosemide 40 mg, Conventional Treatment - Urolithiasis, Nephrolithiasis | Phase 3 | Unknown | Shiraz University of Medical Sciences | 500 | 2020-07-01 | 2022-03-08 |
Breast Neoplasms (1) · Drug-Related Side Effects and Adverse Reactions (1) · Dyspnea (1) · Kidney Calculi (1) · Musculoskeletal Pain (1) · Nephrolithiasis (1) · Ureterolithiasis (1) · Urinary Calculi (1) · Urolithiasis (1)
European Organisation for Research and Treatment of Cancer - EORTC (1) · Shiraz University of Medical Sciences (1) · University Hospital Hradec Kralove (1) · University Hospital, Tours (1)
Czechia (1) · France (1) · Iran (1)
Dariush Irani, MD (1) · Vladimir Koblizek, PhD (1)
2018 (1)